Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Integrated Analysis of Dysregulated miRNA-gene Expression in HMGA2-silenced Retinoblastoma Cells.

Venkatesan N, Deepa P, Vasudevan M, Khetan V, Reddy AM, Krishnakumar S.

Bioinform Biol Insights. 2014 Sep 4;8:177-91. doi: 10.4137/BBI.S16958. eCollection 2014.

PMID:
25232279
[PubMed]
Free PMC Article
2.

A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer.

Bera A, VenkataSubbaRao K, Manoharan MS, Hill P, Freeman JW.

PLoS One. 2014 Sep 3;9(9):e106343. doi: 10.1371/journal.pone.0106343. eCollection 2014.

PMID:
25184537
[PubMed - in process]
Free PMC Article
3.

Regulation of the mRNA half-life in breast cancer.

Griseri P, Pagès G.

World J Clin Oncol. 2014 Aug 10;5(3):323-34. doi: 10.5306/wjco.v5.i3.323. Review.

PMID:
25114848
[PubMed]
Free PMC Article
4.

MicroRNA and HER2-overexpressing Cancer.

Wang SE, Lin RJ.

Microrna. 2013;2(2):137-47.

PMID:
25070783
[PubMed - in process]
Free PMC Article
5.

The expression and significance of five types of miRNAs in breast cancer.

Min W, Wang B, Li J, Han J, Zhao Y, Su W, Dai Z, Wang X, Ma Q.

Med Sci Monit Basic Res. 2014 Jul 21;20:97-104. doi: 10.12659/MSMBR.891246.

PMID:
25047098
[PubMed - in process]
Free PMC Article
6.

MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.

Shah NR, Chen H.

World J Clin Oncol. 2014 May 10;5(2):48-60. doi: 10.5306/wjco.v5.i2.48. Review.

PMID:
24829851
[PubMed]
Free PMC Article
7.

Good guy or bad guy: the opposing roles of microRNA 125b in cancer.

Banzhaf-Strathmann J, Edbauer D.

Cell Commun Signal. 2014 Apr 28;12:30. doi: 10.1186/1478-811X-12-30.

PMID:
24774301
[PubMed - in process]
Free PMC Article
8.

Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.

Tan S, Ding K, Li R, Zhang W, Li G, Kong X, Qian P, Lobie PE, Zhu T.

Breast Cancer Res. 2014 Apr 15;16(2):R40. doi: 10.1186/bcr3644.

PMID:
24735615
[PubMed - in process]
Free PMC Article
9.

MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma.

Liu Y, Li Z, Wu L, Wang Z, Wang X, Yu Y, Zhao Q, Luo F.

Cancer Cell Int. 2014 Mar 7;14(1):24. doi: 10.1186/1475-2867-14-24.

PMID:
24602316
[PubMed]
Free PMC Article
10.

A networks method for ranking microRNA dysregulation in cancer.

Budd WT, Seashols S, Weaver D, Joseph C, Zehner ZE.

BMC Syst Biol. 2013;7 Suppl 5:S3. doi: 10.1186/1752-0509-7-S5-S3. Epub 2013 Dec 9.

PMID:
24564923
[PubMed - in process]
Free PMC Article
11.

Stress-induced ECM alteration modulates cellular microRNAs that feedback to readjust the extracellular environment and cell behavior.

Edeleva EV, Shcherbata HR.

Front Genet. 2013 Dec 31;4:305. doi: 10.3389/fgene.2013.00305. Review.

PMID:
24427166
[PubMed]
Free PMC Article
12.

Review of MicroRNA Deregulation in Oral Cancer. Part I.

Kolokythas A, Miloro M, Zhou X.

J Oral Maxillofac Res. 2011 Jul 1;2(2):e1. doi: 10.5037/jomr.2011.2201. Review.

PMID:
24421988
[PubMed]
Free PMC Article
13.

Adaptive and maladaptive expression of the mRNA regulatory protein HuR.

Govindaraju S, Lee BS.

World J Biol Chem. 2013 Nov 26;4(4):111-8. doi: 10.4331/wjbc.v4.i4.111. Review.

PMID:
24340134
[PubMed]
Free PMC Article
14.

MicroRNAs and triple negative breast cancer.

D'Ippolito E, Iorio MV.

Int J Mol Sci. 2013 Nov 11;14(11):22202-20. doi: 10.3390/ijms141122202. Review.

PMID:
24284394
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms.

Ben-Hamo R, Efroni S.

PLoS Comput Biol. 2013;9(11):e1003351. doi: 10.1371/journal.pcbi.1003351. Epub 2013 Nov 21.

PMID:
24278004
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors.

Aure MR, Leivonen SK, Fleischer T, Zhu Q, Overgaard J, Alsner J, Tramm T, Louhimo R, Alnæs GI, Perälä M, Busato F, Touleimat N, Tost J, Børresen-Dale AL, Hautaniemi S, Troyanskaya OG, Lingjærde OC, Sahlberg KK, Kristensen VN.

Genome Biol. 2013 Nov 20;14(11):R126. doi: 10.1186/gb-2013-14-11-r126.

PMID:
24257477
[PubMed - in process]
Free PMC Article
17.

Regulation of breast cancer and bone metastasis by microRNAs.

Vimalraj S, Miranda PJ, Ramyakrishna B, Selvamurugan N.

Dis Markers. 2013;35(5):369-87. doi: 10.1155/2013/451248. Epub 2013 Sep 26. Review.

PMID:
24191129
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

Feliciano A, Castellvi J, Artero-Castro A, Leal JA, Romagosa C, Hernández-Losa J, Peg V, Fabra A, Vidal F, Kondoh H, Ramón Y Cajal S, Lleonart ME.

PLoS One. 2013 Oct 3;8(10):e76247. doi: 10.1371/journal.pone.0076247. eCollection 2013.

PMID:
24098452
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Overexpression of hsa-miR-125b during osteoblastic differentiation does not influence levels of Runx2, osteopontin, and ALPL gene expression.

Pinto MT, Nicolete LD, Rodrigues ES, Palma PV, Orellana MD, Kashima S, Covas DT.

Braz J Med Biol Res. 2013 Aug;46(8):676-80. doi: 10.1590/1414-431X20132896. Epub 2013 Aug 30.

PMID:
24036939
[PubMed - in process]
Free PMC Article
20.

MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation.

Lei H, Zou D, Li Z, Luo M, Dong L, Wang B, Yin H, Ma Y, Liu C, Wang F, Zhang J, Yu J, Li Y.

PLoS One. 2013 Apr 23;8(4):e60369. doi: 10.1371/journal.pone.0060369. Print 2013.

PMID:
23637748
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk